Digital biomarkers for multiple sclerosis
Symptoms that shift with heat, infection and time of day, assessed by a scale weighted heavily towards walking.
.png)
Multiple sclerosis presents a measurement problem that periodic assessment handles poorly. The condition affects mobility, fatigue, cognition and continence to different degrees in different people, symptoms fluctuate with heat, infection and time of day, and the standard disability scale is weighted heavily towards walking while being relatively insensitive to change at either end of its range.
The digital measures used in this condition concentrate on function in daily life. Walking speed, daily step count, activity intensity and sedentary time describe mobility as it is actually experienced. Sleep measures matter because sleep disruption both contributes to and is confused with the fatigue that people with multiple sclerosis describe as their most limiting symptom.
Fatigue deserves particular note. It is consistently reported as among the most disabling features of the condition and it has no objective measure. Activity data does not measure fatigue, but it does describe the behavioural consequence of it, including the pattern of activity followed by prolonged recovery that people describe and that a single clinic visit cannot observe.
Digital biomarkers used in multiple sclerosis research
How these measures are used
The main research use is capturing functional change at higher resolution than the conventional disability scale allows. Continuous walking measures can detect deterioration or improvement that the scale does not register, particularly in people whose disability sits within a range where the scale moves slowly.
Real world measurement also addresses the gap between tested and actual walking. A person can complete a timed walk in clinic and still walk very little at home because of fatigue, heat sensitivity or unpredictability, and only continuous measurement observes that.
The third use is characterising variability. Symptoms in multiple sclerosis fluctuate day to day and within days, and averaging that away discards clinically relevant information. These measures are reported alongside the standard disability assessment and validated patient reported instruments covering fatigue and quality of life, which capture the subjective burden that activity data does not.
What the evidence supports today
Walking measures in multiple sclerosis draw on the same technical validation as the wider mobility domain, and the condition was included in the multi cohort validation programme of the Mobilise-D consortium, which strengthens the case for bout level measures specifically in this population.
Observational evidence links reduced daily activity to disability progression and to quality of life in multiple sclerosis, and activity measures have been used as outcomes in rehabilitation and exercise trials. What is less established is a minimal important difference for most of these measures in this population, which constrains their interpretation as standalone endpoints.
Two limitations deserve emphasis. Gait in multiple sclerosis is variable and can be atypical, so step detection accuracy from general population validation should not be assumed. And heat sensitivity means that ambient temperature is a genuine confounder of activity data in this condition rather than a theoretical one, so studies that do not record it will misinterpret seasonal variation as disease change.
Common questions
Which digital measures are used in multiple sclerosis research?
Predominantly mobility measures, including walking speed, daily step count, activity intensity and sedentary time, together with sleep measures. These describe function in daily life at a resolution the conventional disability scale does not reach.
Can wearables measure fatigue?
Not directly. Fatigue is a subjective experience with no objective equivalent. What activity data can describe is its behavioural consequence, including reduced activity and the pattern of exertion followed by prolonged recovery. Fatigue itself is measured with validated questionnaires, and the two should be reported together.
Do these measures add anything beyond the standard disability scale?
Yes. The conventional scale is heavily weighted towards walking ability and is relatively insensitive to change in parts of its range. Continuous measures can detect functional change that the scale does not register, and they describe what happens between assessments rather than only at them.
What confounds activity measurement in multiple sclerosis?
Heat sensitivity is the distinctive one. Many people with multiple sclerosis experience worse symptoms in warm conditions, so ambient temperature affects activity data directly and seasonal variation can be mistaken for disease change. Atypical gait also reduces the accuracy of step detection algorithms validated on general populations.
Run a study on these measures
WeGuide captures wearable data and patient reported outcomes in one platform, from screening through to analysis.
